Sage Therapeutics, Inc
SAGE Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Insiders
Institutions
Government
Ownership
Income
Balance Sheet
Cash Flow
SAGE Income Statement
SAGE Balance Sheet
SAGE Cash Flow
Recent trades of SAGE by members of U.S. Congress
SAGE Stock Insider Trading Activity
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
SAGE Stock Institutional Owners
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
SAGE Derivatives Institutional Owners
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by SAGE's directors and management
Government lobbying spending instances
-
$120,000 Oct 18, 2024 Issue: Medicare/Medicaid Health Issues
-
$140,000 Jul 19, 2024 Issue: Medicare/Medicaid Health Issues
-
$140,000 Apr 22, 2024 Issue: Medicare/Medicaid Health Issues
-
$110,000 Jan 19, 2024 Issue: Medicare/Medicaid Health Issues
-
$140,000 Oct 18, 2023 Issue: Medicare/Medicaid Health Issues
-
$130,000 Jul 19, 2023 Issue: Medicare/Medicaid Health Issues
-
$110,000 Jan 19, 2023 Issue: Medicare/Medicaid Health Issues
-
$120,000 Oct 20, 2022 Issue: Medicare/Medicaid Health Issues
-
$284,000 Oct 19, 2022 Issue: Medicare/Medicaid Health Issues
-
$197,756 Apr 19, 2022 Issue: Medicare/Medicaid Health Issues
-
$197,756 Jan 20, 2022 Issue: None
-
$275,000 Oct 22, 2021 Issue: None
-
$275,000 Jul 20, 2021 Issue: None
-
$287,000 Apr 20, 2021 Issue: None
-
$223,000 Jan 20, 2021 Issue: None
-
$287,000 Oct 19, 2020 Issue: None
-
$166,315 Jul 20, 2020 Issue: HEALTH ISSUES
-
$218,437 Apr 22, 2020 Issue: HEALTH ISSUES
-
$229,013 Jan 21, 2020 Issue: HEALTH ISSUES
-
$206,000 Oct 21, 2019 Issue: Health Issues
-
$154,000 Jul 22, 2019 Issue: Health Issues Copyright/Patent/Trademark
-
$50,000 Apr 22, 2019 Issue: Health Issues
-
$50,000 Jan 22, 2019 Issue: Health Issues
-
$50,000 Oct 16, 2018 Issue: Health Issues
-
$50,000 Jul 20, 2018 Issue: Health Issues
-
$30,000 Apr 19, 2018 Issue: Health Issues
-
$10,000 Oct 17, 2012 Issue: Defense Medical/Disease Research/Clinical Labs
-
$30,000 Jul 12, 2012 Issue: Medical/Disease Research/Clinical Labs Defense
-
$30,000 Apr 16, 2012 Issue: Medical/Disease Research/Clinical Labs Defense
-
$30,000 Jan 10, 2012 Issue: Medical/Disease Research/Clinical Labs Defense
-
$30,000 Oct 12, 2011 Issue: Defense Medical/Disease Research/Clinical Labs
-
$30,000 Jul 16, 2011 Issue: Defense Medical/Disease Research/Clinical Labs
-
$20,000 Apr 18, 2011 Issue: Medical/Disease Research/Clinical Labs Defense
Estimated quarterly lobbying spending
U.S. Patents
New patents grants
-
Patent Title: Oxysterols and methods of use thereof Oct. 29, 2024
-
Patent Title: Neuroactive steroids, compositions, and uses thereof Oct. 29, 2024
-
Patent Title: Crystalline forms of a neuroactive steroid Oct. 22, 2024
-
Patent Title: Neuroactive steroids, compositions, and uses thereof Sep. 10, 2024
-
Patent Title: Neuroactive steroids, compositions, and uses thereof Aug. 27, 2024
-
Patent Title: Compositions and methods for treating cns disorders Aug. 20, 2024
-
Patent Title: Compositions and methods for treating cns disorders Aug. 13, 2024
-
Patent Title: Methods of treating epilepsy or status epilepticus Jul. 30, 2024
-
Patent Title: Neuroactive steroids and their methods of use Jun. 04, 2024
-
Patent Title: C7, c12, and c16 substituted neuroactive steroids and their methods of use May. 28, 2024
-
Patent Title: Neuroactive steroids and their methods of use Apr. 30, 2024
-
Patent Title: Crystalline forms of a neuroactive steroid Apr. 09, 2024
-
Patent Title: Compositions and methods for treating cns disorders Apr. 02, 2024
-
Patent Title: C7 substituted oxysterols and methods of use thereof Mar. 12, 2024
-
Patent Title: Neuroactive steroids and their methods of use Feb. 27, 2024
-
Patent Title: Neuroactive steroids and methods of use thereof Feb. 20, 2024
-
Patent Title: Oxysterols and methods of use thereof Jan. 30, 2024
-
Patent Title: Crystalline 19-nor c3,3-disubstituted c21-n-pyrazolyl steroid Jan. 30, 2024
-
Patent Title: Oxysterols and methods of use thereof Jan. 23, 2024
-
Patent Title: Oxysterols and methods of use thereof Dec. 26, 2023
-
Patent Title: Neuroactive steroids, compositions, and uses thereof Oct. 10, 2023
-
Patent Title: Oxysterols and methods of use thereof Aug. 22, 2023
-
Patent Title: Compositions and methods for treating cns disorders Aug. 08, 2023
-
Patent Title: Compositions and methods for treating cns disorders Jun. 06, 2023
-
Patent Title: Neuroactive steroids and compositions thereof May. 09, 2023
-
Patent Title: Neuroactive steroids substituted in position 10 with a cyclic group for use in the treatment of cns disorders Apr. 25, 2023
-
Patent Title: Oxysterols and methods of use thereof Mar. 28, 2023
-
Patent Title: Neuroactive steroids, compositions, and uses thereof Jan. 17, 2023
-
Patent Title: Compositions and methods for treating cns disorders Jan. 03, 2023
-
Patent Title: Compositions and methods for treating cns disorders Dec. 20, 2022
-
Patent Title: Neuroactive steroids, compositions, and uses thereof Nov. 15, 2022
-
Patent Title: Neuroactive steroid formulations and methods of treating cns disorders Aug. 30, 2022
-
Patent Title: Oxysterols and methods of use thereof Aug. 09, 2022
-
Patent Title: C17, c20, and c21 substituted neuroactive steroids and their methods of use Jul. 26, 2022
-
Patent Title: 19-nor c3, 3-disubstituted c21-c-bound heteroaryl steroids and methods of use thereof May. 31, 2022
-
Patent Title: Oxysterols and methods of use thereof Mar. 22, 2022
-
Patent Title: 19-nor neuroactive steroids and methods of use thereof Mar. 01, 2022
-
Patent Title: 19-nor c3, 3-disubstituted c21-n-pyrazolyl steroids and methods of use thereof Feb. 08, 2022
-
Patent Title: Crystalline 19-nor c3,3-disubstituted c21-n-pyrazolyl steroid Feb. 01, 2022
-
Patent Title: Neuroactive steroids, compositions, and uses thereof Oct. 19, 2021
-
Patent Title: C7 substituted oxysterols and methods of use thereof Oct. 19, 2021
-
Patent Title: Oxysterols and methods of use thereof Oct. 19, 2021
-
Patent Title: Compositions and methods for treating cns disorders Oct. 19, 2021
-
Patent Title: Neuroactive steroids, compositions, and uses thereof Sep. 21, 2021
-
Patent Title: Oxysterols and methods of use thereof Sep. 14, 2021
-
Patent Title: Oxysterols and methods of use thereof Sep. 07, 2021
-
Patent Title: Neuroactive steroids and methods of use thereof Aug. 31, 2021
-
Patent Title: Neuroactive steroids, compositions, and uses thereof Jun. 29, 2021
-
Patent Title: Neuroactive steroids, compositions, and uses thereof Mar. 09, 2021
-
Patent Title: Compositions and methods for treating cns disorders Dec. 22, 2020
Government Contracts
Federal grants, loans, and purchases
Government Contracts
Estimated quarterly amount awarded from public contracts
WallStreetBets
Number of mentions of SAGE in WallStreetBets Daily Discussion
SAGE News
Recent insights relating to SAGE
CNBC Recommendations
Recent picks made for SAGE stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in SAGE
SAGE Top Shareholders
|
Shareholder
|
Shares Held
|
|---|
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
SAGE Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view SAGE Smart Score
Score Breakdown
Bull Case vs Bear Case
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
Bulls Say:
The Bulls Say summary highlights positive aspects of the stock.
Bears Say:
The Bears Say summary points out potential risks and negative aspects of the stock.
Show More